Skip to Content

Mecasermin rinfabate Pregnancy and Breastfeeding Warnings

Mecasermin rinfabate is also known as: iPlex

Mecasermin rinfabate Pregnancy Warnings

Mecasermin rinfabate has been assigned to pregnancy category C by the FDA. Animal studies have failed to reveal evidence of embryofetal toxicity or teratogenicity. There are no controlled data in human pregnancy. Mecasermin rinfabate is only recommended for use during pregnancy when benefit outweighs risk.

See references

Mecasermin rinfabate Breastfeeding Warnings

There are no data on the excretion of mecasermin rinfabate into human milk. The manufacturer recommends that caution be used when administering mecasermin rinfabate to nursing women.

See references

References for pregnancy information

  1. "Multum Information Services, Inc. Expert Review Panel"

References for breastfeeding information

  1. "Multum Information Services, Inc. Expert Review Panel"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide